These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19178601)

  • 1. The search for an oral prostanoid to treat pulmonary arterial hypertension continues. Are we getting any closer?
    Rich J; Hoeper MM
    Int J Clin Pract Suppl; 2009 Mar; (161):17-8. PubMed ID: 19178601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostanoid therapy for pulmonary arterial hypertension.
    Strauss WL; Edelman JD
    Clin Chest Med; 2007 Mar; 28(1):127-42; ix. PubMed ID: 17338932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostanoid therapy for pulmonary arterial hypertension.
    Badesch DB; McLaughlin VV; Delcroix M; Vizza CD; Olschewski H; Sitbon O; Barst RJ
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostacyclin therapy for pulmonary arterial hypertension: new directions.
    Gomberg-Maitland M; Preston IR
    Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosing considerations in the use of intravenous prostanoids in pulmonary arterial hypertension: an experience-based review.
    Oudiz RJ; Farber HW
    Am Heart J; 2009 Apr; 157(4):625-35. PubMed ID: 19332188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral treprostinil diethanolamine for pulmonary arterial hypertension.
    Feldman J; Im Y; Gill K
    Expert Rev Clin Pharmacol; 2015 Jan; 8(1):55-60. PubMed ID: 25409915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral treprostinil in the treatment of pulmonary arterial hypertension.
    Feldman J; Habib N; Radosevich J; Dutt M
    Expert Opin Pharmacother; 2017 Oct; 18(15):1661-1667. PubMed ID: 28922964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New and future therapies in pulmonary arterial hypertension.
    Bull TM
    Semin Respir Crit Care Med; 2005 Aug; 26(4):429-36. PubMed ID: 16121320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-release oral treprostinil for the treatment of pulmonary arterial hypertension.
    Skoro-Sajer N; Lang I
    Expert Rev Cardiovasc Ther; 2014 Dec; 12(12):1391-9. PubMed ID: 25363827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treprostinil for pulmonary hypertension.
    Vachiéry JL; Naeije R
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):183-91. PubMed ID: 15151467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of prostacyclin and its analogs in the management of pulmonary arterial hypertension.
    Dandel M; Hetzer R
    Curr Vasc Pharmacol; 2003 Jun; 1(2):171-81. PubMed ID: 15320842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension.
    Sitbon O; Manes A; Jais X; Pallazini M; Humbert M; Presotto L; Paillette Ld; Zaccardelli D; Davis G; Jeffs R; Simonneau G; Galie N
    J Cardiovasc Pharmacol; 2007 Jan; 49(1):1-5. PubMed ID: 17261956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension--seven sites, United States, 2003-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(8):170-2. PubMed ID: 17332729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in prostacyclin therapy for pulmonary arterial hypertension.
    Eells PL
    Crit Care Nurse; 2004 Apr; 24(2):42-8, 50-4. PubMed ID: 15098310
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary arterial hypertension.
    Murali S
    Curr Opin Crit Care; 2006 Jun; 12(3):228-34. PubMed ID: 16672782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin and its analogues in the treatment of pulmonary hypertension.
    Olschewski H; Rose F; Schermuly R; Ghofrani HA; Enke B; Olschewski A; Seeger W
    Pharmacol Ther; 2004 May; 102(2):139-53. PubMed ID: 15163595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral Prostanoids in Pediatric Pulmonary Arterial Hypertension: Start Early, Dose High, Combine.
    Douwes JM; Zijlstra WMH; Rosenzweig EB; Ploegstra MJ; Krishnan US; Haarman MG; Roofthooft MTR; Postmus D; Hillege HL; Ivy DD; Berger RMF
    Ann Am Thorac Soc; 2022 Feb; 19(2):227-237. PubMed ID: 34181866
    [No Abstract]   [Full Text] [Related]  

  • 18. [Update: Current clinical developments in pulmonary hypertension].
    Dumitrescu D; Ghofrani HA; Grimminger F; Hoeper MM; Rosenkranz S
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S160-3. PubMed ID: 19718605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of pulmonary arterial hypertension].
    Olschewski H; Ghofrani A; Enke B; Reichenberger F; Voswinckel R; Kreckel A; Ghofrani S; Wiedemann R; Schulz R; Grimminger F; Seeger W
    Internist (Berl); 2005 Mar; 46(3):341-9. PubMed ID: 15703889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic evaluation of treprostinil (oral) for the treatment of pulmonary arterial hypertension.
    Hellawell JL; Bhattacharya S; Farber HW
    Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1445-53. PubMed ID: 25204984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.